This story was first published in digitalhealth.net

A new macula centre which offers the very latest in imaging technology is to officially open in Bradford.
The Bradford Macula Centre is part of Bradford Teaching Hospitals NHS Foundation Trust. It features the most sophisticated scanning equipment capable of detecting a number of eye conditions and is playing a leading role in eye health in the city.
The new centre means that patients with suspected wet macular degeneration will be seen and treated for the condition quicker, improving the success of the treatment. It is hoped to be able to see twice as many patients and the number of clinics will be increased from five per week, run over two and a half days at present, to 10 clinics over five days.
Formerly the trust’s macular service was based in the pain management clinic in the grounds of St Luke’s.
The project has been a joint working agreement with Bayer Pharmaceuticals, a life science company dedicated to working with the NHS to develop solutions to improve retinal services and the provision of care for patients. Bayer funded a new optical coherence tomography scanner for the unit.
Helen Devenport, consultant ophthalmic surgeon, said: “This scanner allows us to see detailed images of the retina (the lining of the back of the eye), enabling us to accurately detect, monitor and manage changes to the retina. This latest technology allows us to see flow in blood vessels in the retina without having to inject patients with dye. Previously abnormal blood vessels could only be detected on photos taken after patients received an intravenous injection of one or two dyes. So we are very grateful to Bayer for their support.”
Jackie Napier, medical director for ophthalmology at Bayer, said: “We are proud to support NHS trusts across the UK to improve care for people with sight-threatening eye conditions. We need to continue to work together as an ophthalmology community to overcome challenges in service delivery so we can preserve patients’ sight as much as possible.”
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly